INTERVIEWS

Guests:Guests: Dr. David Fisher, M.D and Lani

Presenter: Neal Howard

Guest Bio: David Fisher, M.D., is Director of the Total Joint Center of Excellence at OrthoIndy Hospital (Indianapolis, Indiana) and an Assistant Clinical Professor of Orthopaedic Surgery at the Indiana University School of Medicine. He performs more than 500 joint replacement procedures a year and specializes in primary and revision knee replacement.

Lani is a small animal veterinarian and equestrian physical therapist who provides chiropractic, therapeutic laser and massage therapy for competitive race horses. A nature and animal enthusiast, Lani has had a lifelong passion for being active outdoors, camping, hiking and riding horses.
Lani’s knee problems started in 1996 when she tore her anterior cruciate ligament (ACL) in her left knee during a horse riding accident.
Despite the surgery, Lani’s pain progressed, and it became physically difficult for her to perform her job, which required her to be on her feet all day.
In 2013, Lani went ahead with a double knee replacement procedure and is back to working, riding and living an active, pain-free life.

Segment overview: Dr. David Fisher discusses the impact of Osteoarthritis on Women and treatment options for dealing with pain.

Guest: Paul Gionfriddo

Presenter: Neal Howard

Guest Bio: Paul Gionfriddo was named President and CEO of Mental Health America on May 1, 2014. He has worked in a variety of health and mental-health related positions during a career spanning over thirty years.
Paul has also led nonprofit organizations in three states. He served as President of the Quantum Foundation, a private health foundation in Palm Beach County FL from 2007 to 2010 and as Executive Director of the Palm Beach County Community Health Alliance from 2005 to 2007. He is a graduate of Wesleyan University. He lives with his wife, Pam, who is CEO of the Mental Health Association of Palm Beach County, in Lake Worth, Florida. They have five adult children and two grandchildren.

Segment overview: Paul Gionfriddo, President, and CEO of Mental Health America discusses the crucial need for increased awareness and dialogue (among patients, caregivers, and HCPs) about the emotional and communication needs of the patient journey.

Guest: Dr. Keri Donaldson

Presenter: Neal Howard

Guest Bio: Dr. Keri Donaldson’s work as Medical Director and CEO of Prescient Medicine is fueled by an extensive background in the fields of pathology, genomics, and diagnostics. An active ad hoc reviewer and consultant, Dr. Donaldson has earned a reputation as an innovative member of the medical community and garnered key positions within respected institutions and national committees. He was certified as a diplomate of both the American Board of Pathology and the National Board of Medical Examiners, and holds a BS from Pennsylvania State University, an MD from Temple University School of Medicine, and a master of science in clinical epidemiology (MSCE) from the University of Pennsylvania School of Medicine.

Segment overview: Dr. Keri Donaldson, CEO of Prescient Medicine, talks about the Opioid Epidemic and the FDA’s recent request that a painkiller be pulled from the market by its manufacturer. Also discussed is the first Annual “Solving The Opioid Crisis” Summit.

Guest: Dr. Joe McEvoy

Presenter: Neal Howard

Guest Bio: Dr. McEvoy is a distinguished, tenured professor of psychiatry and health behaviors at Augusta University. He also serves as the I. Clark Case chair in psychotic disorders and as the director of public psychiatry in Augusta University’s partnership with the Georgia Department of Behavioral Health and Developmental Disabilities (DBHDD). His research and clinical work have focused on severe and persistent mental disorders (primarily schizophrenia, schizoaffective disorder, and bipolar disorder). He is currently the principal investigator for the NIMH-funded ACLAIMS (A Comparison of Long-Acting Injected Medications for Schizophrenia) trial.

Segment overview: Dr. Joe McEvoy, professor of psychiatry and health behaviors at Augusta University talks about the review data published in AJP (American Journal of Psychiatry) and the growing body of research that is reshaping the way we look at treatment options for people with schizophrenia.

Guest: Dr. Joe McEvoy

Presenter: Neal Howard

Guest Bio: Dr. McEvoy is a distinguished, tenured professor of psychiatry and health behaviors at Augusta University. He also serves as the I. Clark Case chair in psychotic disorders and as the director of public psychiatry in Augusta University’s partnership with the Georgia Department of Behavioral Health and Developmental Disabilities (DBHDD). His research and clinical work have focused on severe and persistent mental disorders (primarily schizophrenia, schizoaffective disorder, and bipolar disorder). He is currently the principal investigator for the NIMH-funded ACLAIMS (A Comparison of Long-Acting Injected Medications for Schizophrenia) trial.

Segment overview: Dr. Joe McEvoy, professor of psychiatry and health behaviors at Augusta University discusses the current schizophrenia landscape, recent FDA approvals, and real world experience in how his patients face unique challenges as a result of their disease.

Guest: Adam Miller

Presenter: Henry Acosta

Guest Bio: Founder of BuddingTech and The Medical Cannabis Council, Adam completed his studies of Business Entrepreneurship at Royal Melbourne Institute of Technology and Sweden’s Jönköping University for international business in 2009. In 2016 Adam published two Australian industry White Papers with MGC Pharmaceuticals & The University of Sydney on medical cannabis. Additionally, Adam is the organiser of Seedlings, Australia first medical cannabis innovation conference.

Segment overview: In today’s Health Supplier Segment, we welcome Adam Miller here to discuss the launching of The Medical Cannabis Council this week in Melbourne. The Council will be the peak industry body that aims to develop best practice and standards for producing, supplying and distributing medical cannabis products. The founding members are industry leaders and experts in the fields of health and medical cannabis, including CEO of Epilepsy Action Australia, Carol Ireland; Director of Neurology at St. Vincent’s hospital in Melbourne, Professor Mark Cook; and preventative health expert and cardiologist, Dr Ross Walker. The Council will position Australia as a world leader in research and the production of safe, scientifically-backed, medical cannabis products. The launch comes during Medical Cannabis Awareness Week.

Guest: Michael Randall
Presenter: Henry Acosta
Guest Bio: Michael Randall is the CEO, Mediband since January 2004. During this time he launched several successful medical and health business units including TGA medical devices. His prior work includes roles in teaching international marketing & business; land and property management; and international business management.
As Mediband CEO he launched MedibandPlus, FeverMates medical device range and MediBC and oversaw expansion of Mediband to the USA, UK, South Africa, New Zealand amongst other countries. He lectured in International Marketing & business at the University of Technology, Sydney, July 1999 – December 2000; Chief Operating Officer at Frome Street Group of Companies; January 1990 – June 2003.

Segment overview: Mediband provides ready-to-wear and custom engraved identification alert bracelets in various styles – our signature product is the silicone based medical ID. MedibandPlus is an additional and optional emergency medical information service providing 24hr-accessible web-based medical information to medical personnel and first responders in emergencies. Mediband medical alert bracelets provide peace of mind so that when the unexpected happens, critical medical information can be conveyed to emergency personnel. These are helpful in making sure incorrect diagnosis and treatment is preveted, raising awareness of medical conditions such as allergies, and providing vital medical and contact information in emergencies.
Mediband® bracelets can be linked to the MedibandPlus web-based medical database enabling subscribers to store medical information for emergency access. The wristbands are available in a range of colours and sizes. They are also designed to break when enough force is applied to prevent snagging or catching injuries. MediBC provides access to a large range of first aid kits by St John and Trafalgar in addition to St John first aid training courses. Fevermates are a convenient, easy-to-read, fuss free stick-on fever & temperature indicators that allow you to continuously monitor your children’s fever or temperature for up to 48 hours at a glance.

Guest: Dr. Ross Macdonald

Presenter: Henry Acosta

Guest Bio: Doctor Ross Macdonald is the CEO of Cynata Therapeutics, an Australian clinical stage regenerative medicine company that is developing a therapeutic stem cell technology called Cymerus, that allows for the mass production of stem cells. They recently began a world-first Phase I clinical trial into the effectiveness of their technology in treating patients with acute steroid-resistant graft-versus-host disease.

Segment overview: In today’s Health Supplier Segment, we are joined by the CEO of Cynata Therapeutics Dr. Ross Macdonald here to share update about their Cymerus™ technology to treat patients with steroid-resistant acute graft versus host disease (GvHD). The Cymerus platform allows for the mass-production of mesenchymal stem cells (MSCs) of a uniformly high quality using cells derived from a single blood donation. The first product currently being tested with the first patient treated a short time ago in the UK is called CYP-001, intended for the treatment of GvHD. Dr Ross hopes to one day increase the effective treatment options available to patients with life-threatening conditions such as acute steroid-resistant GvHD. According to him, if this present clinical trial is successful it will open up the door to many other potential therapeutic uses for Cynata’s unique Cymerus MSC technology. MSCs are currently being studied in over 650 clinical trials and Cynata itself already has strong data in pre-clinical models of heart attack and asthma, as well as other diseases, creating a very promising commercial opportunity for the company.

Guest: Dr. Allen Gabriel

Presenter: Neal Howard

Guest Bio: Board certified plastic surgeon, Dr. Allen Gabriel understands that plastic and reconstructive surgery provides a unique opportunity to deal with a wide variety of needs ranging from addressing congenital anomalies, to breast reconstruction following mastectomy, to aesthetic procedures such as breast and facial cosmetic procedures. A member of the American Society of Plastic Surgeons, Dr. Gabriel has the extensive training and education and practices in the Portland, OR area.

Segment overview: Dr. Allen Gabriel, a board certified plastic surgeon, discusses the latest in breast reconstruction and reducing the risk for surgical site infections.